$AUTL
Autolus Therapeutics plc
PRICE
$1.82 -
Extented Hours
VOLUME
296,048
DAY RANGE
1.74 - 1.84
52 WEEK
1.6 - 4.73
Key Metrics
Market Cap
315 M
Beta
0.87
Avg. Volume
458.53 K
Shares Outstanding
173.07 M
Yield
0%
Public Float
0
Next Earnings Date
2023-05-04
Next Dividend Date
Company Information
Autolus Therapeutics plcis a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
Website: www.autolus.com
HQ: Scale Space Building 58 Wood Lane, W12 7RZ London
Related News